Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -71,269 | -64,465 | -37,685 | -30,637 | 0 |
| Depreciation Amortization | 1,373 | 1,108 | 975 | 377 | N/A |
| Accounts receivable | 0 | 663 | -663 | 600 | N/A |
| Accounts payable and accrued liabilities | -122 | 2,381 | -2,151 | 2,938 | 0 |
| Other Working Capital | 173 | 5,103 | -649 | 1,621 | N/A |
| Other Operating Activity | 7,243 | 3,143 | -5,685 | -8,577 | 0 |
| Operating Cash Flow | $-62,602 | $-52,067 | $-45,858 | $-33,678 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -532 | -267 | -576 | -2,428 | N/A |
| Investing Cash Flow | $-532 | $-267 | $-576 | $-2,428 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 95,271 | N/A |
| Common Stock Issued | 47,884 | 101,931 | 55 | 236 | 0 |
| Other Financing Activity | 0 | -960 | 0 | 5,462 | 0 |
| Financing Cash Flow | $47,884 | $100,971 | $55 | $100,969 | $0 |
| Beginning Cash Position | 87,304 | 38,667 | 85,046 | 20,183 | N/A |
| End Cash Position | 72,054 | 87,304 | 38,667 | 85,046 | N/A |
| Net Cash Flow | $-15,250 | $48,637 | $-46,379 | $64,863 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -62,602 | -52,067 | -45,858 | -33,678 | 0 |
| Capital Expenditure | -552 | -267 | -576 | -2,428 | 0 |
| Free Cash Flow | -63,154 | -52,334 | -46,434 | -36,106 | 0 |